The FY26 Toxic Exposures Research Program Clinical Trial Award supports clinical trials aimed at preventing, treating, or managing conditions from military-related toxic exposures. It funds projects ranging from small proof-of-concept trials to large-scale efficacy studies. The award encourages interdisciplinary partnerships through a Partnering Principal Investigator Option to accelerate clinical application of promising interventions.
Open to any type of entity, with no specific restrictions stated. Eligible applicants include a broad range of organizations and individuals.
